NCT06171737

Brief Summary

The goal of this study is to increase shared decision making for patients considering treatment for severe aortic stenosis. The main questions it aims to answer are:

  • Do patient decision aids and clinician skills training course improve the quality of decisions, and do they work well for different patient populations?
  • Are heart clinics able to reach the majority of patients with decision aids before their specialist visit and do the majority of clinicians complete the training course? All participating sites will start in the usual care group and then will be randomly assigned a time to switch to the intervention group. Participants will complete surveys before and after their specialist visit. Researchers will compare data from patients seen during usual care with data from those seen after the interventions are implemented to see if there are improvements in the quality of decisions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,300

participants targeted

Target at P75+ for not_applicable

Timeline
18mo left

Started Mar 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

8 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Mar 2024Oct 2027

First Submitted

Initial submission to the registry

December 5, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

March 27, 2024

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Last Updated

June 8, 2025

Status Verified

June 1, 2025

Enrollment Period

3.2 years

First QC Date

December 5, 2023

Last Update Submit

June 4, 2025

Conditions

Keywords

aortic valve stenosisDecision Making, Shareddecision aidcontinuing medical educationcardiologyTranscatheter Aortic Valve Replacement

Outcome Measures

Primary Outcomes (1)

  • Shared Decision Making

    Shared Decision Making Process scale; Scores range 0-4 with higher scores indicating greater shared decision making occurred.

    About 1 week post visit

Secondary Outcomes (8)

  • Reach

    About 1 week post visit

  • Patient Knowledge

    About 1 week post visit

  • Preference-treatment concordance

    About 1 week post visit

  • Patient experience

    About 1 week post visit

  • Clinician satisfaction

    About 1 week post visit

  • +3 more secondary outcomes

Study Arms (2)

Control (usual care)

NO INTERVENTION

This group will receive usual care without any support for using the decision aid and without any access to the clinician training.

Intervention

ACTIVE COMPARATOR

The patients in this group will receive a decision aid that covers the main treatment options for aortic stenosis. The clinicians in this group will receive a 60-minute online training session that will provide practical tips, interactive case studies and tools for conducting shared decision making conversations covering core competencies

Behavioral: Decision AidBehavioral: Shared Decision Making Skills Training

Interventions

Decision AidBEHAVIORAL

The American College of Cardiology decision aid: Treatment Options for Severe Aortic Stenosis for patients deciding between Tavi and Surgery

Intervention

60-minute online training session that will provide practical tips, interactive case studies and tools for conducting shared decision making conversations covering core competencies

Intervention

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Between 65-85 years of age
  • Language is English or Spanish
  • Diagnosed with severe aortic stenosis defined as (e.g. an aortic valve area \< 1 cm2 or as determined by clinician)
  • Attend a scheduled visit with an Interventional Cardiologist and/or Cardiac Surgeon from the Heart Valve Team at a participating site

You may not qualify if:

  • Prior aortic valve replacement surgery
  • High risk for either SAVR or TAVI (e.g., Society of Thoracic Surgery score \>8% or clinician determined)
  • Prior coronary artery bypass surgery (CABG)
  • End stage renal disease on dialysis
  • Severe lung disease (chronic obstructive pulmonary disease; COPD) requiring home oxygen
  • Advanced Cirrhosis
  • Unable to consent for self (proxy respondents are not allowed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

The Regents of the University of California, San Francisco

San Francisco, California, 94117, United States

Location

University of Colorado Denver

Aurora, Colorado, 80045-7202, United States

Location

Emory University

Atlanta, Georgia, 30308-0000, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599-1350, United States

Location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

UT Southwestern Medical Center

Dallas, Texas, 75390-9020, United States

Location

Related Publications (1)

  • Sepucha K, Elmariah S, Valentine KD, Cavender MA, Chang Y, Devireddy CM, Dickert NW, Gama KD, Knoepke CE, Korngold E, Kumbhani DJ, Matlock DD, Messenger JC, Strong S, Thourani VH, Nathan A, Quader N, Brescia AA. The IMproving treatment decisions for Patients with AortiC stenosis Through Shared Decision Making (IMPACT SDM) Study: study protocol for a cluster randomized stepped wedge trial. Trials. 2024 Dec 18;25(1):820. doi: 10.1186/s13063-024-08640-6.

MeSH Terms

Conditions

Aortic Valve Stenosis

Interventions

Decision Support Techniques

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Karen Sepucha, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
  • Sammy Elmariah, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
There is limited blinding in the trial due to the pragmatic focus and batched stepped wedge design. Patients will be told that the study is testing different types of decision support and while they will not be blinded to the materials they receive, they will not know what materials other patients receive. Clinicians and staff will be involved in delivery of the decision aids and will not be blinded to the study arm. Research staff entering survey data and conducting chart review will not be given any explicit information about study assignment; however, it is likely that they will have a sense for the arm due to the timing. The statistician conducting analyses will be blinded to group assignment at each step. For the clinician survey, we will use computer generated random assignment to select one specialist (either interventional cardiologist or cardiac surgeon) to receive the post-visit survey for each patient participant.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 5, 2023

First Posted

December 15, 2023

Study Start

March 27, 2024

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

October 31, 2027

Last Updated

June 8, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

To promote research replicability, transparency and future use of the data, de-identified data sets will be created and will be available, by request, to outside researchers. The Data Package (comprised of the de-identified Analyzable Data Set, Full Protocol, metadata, data dictionary, full statistical analysis plan, and analytic code from the project) will be deposited in the Patient-Centered Outcomes Research Institute's Data Repository at the ICPSR. Participant information sheets for the study will indicate that de-identified information will be deposited in an open access service to promote use of the data by other researchers. No information that contains identifiers or that could be used to link an individual to the data will be included in the de-identified data set. No data will be provided from qualitative transcripts as this may lead to identifying information about participants. However, codes abstracted from qualitative transcripts may be made available.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
The PCORI-designated repository will make the data available for third-party requests when PCORI makes the Final Research Report available, or at the time of publication the primary results, whichever comes first.
Access Criteria
Researchers may access the data through the PCORI-designated repository (ICPSR's website) once it is made available.

Locations